 Home > Medical News > Latest Medical News > Bojian's non-opioid painkiller vixotrigine phase II trial failed

Bojian's non-opioid painkiller vixotrigine phase II trial failed

 Last Update: 2021-10-11
 Source: Internet
 Author: User

Tags

parkinson's treatment drug

solid phase

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationTom Lee

A few days ago, Biogen announced that the non-opioid painkiller vixotrigine failed to achieve the expected goal of reducing the average daily pain of patients during the interim study.

The drug was originally acquired by Bojian's acquisition of Covergence for 675 million in 2015

However, Biogen claimed that vixotrigine achieved a significant improvement in another secondary endpoint (the patient’s self-reported symptom improvement score)

In terms of safety, the two doses of vixotrigine were generally well tolerated by patients, and no potential evidence of opioid abuse was found during the trial

It is worth noting that this is not the first time vixotrigine has faced trial setbacks

Reference source: Biogen's non-opioid painkiller drops another phase 2 trial, this time in sensory pain disorder

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.